Two hotspot mutations, occurred collectively in around 10% of PTC, in the core promoter region of TERT activates the expression of TERT at the transcription level and thus promotes the tumorigenesis and development of thyroid cancer (4, 9–11). Here, TERT is linked to thyroid gland carcinoma.